These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 4660914)
41. A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2. Neuhaus W; Lauer R; Oelzant S; Fringeli UP; Ecker GF; Noe CR J Biotechnol; 2006 Aug; 125(1):127-41. PubMed ID: 16730091 [TBL] [Abstract][Full Text] [Related]
42. [Animal experimental studies on the permeability effectiveness of modern drugs (psychotropic drugs and antigoagulants) together with a contribution on different modes of action on the blood-brain barrier]. Liebaldt G Arzneimittelforschung; 1965 Sep; 15(9):1056-60. PubMed ID: 4159770 [No Abstract] [Full Text] [Related]
43. [Results of experimental studies of 51chromium-albumin kinetics following intravenous administration of Hylase "Dessau"]. Dahlke J; Hartig W; Bellmann H; Hutschenreiter J; Löbe J; Schönlebe W Z Exp Chir; 1979; 12(1):2-14. PubMed ID: 463167 [TBL] [Abstract][Full Text] [Related]
44. Electron microscopical studies on Thorotrast permeability across the brain capillaries in rabbits. I. Observations in the normal brain. Kinjo K Kumamoto Med J; 1976 Mar; 29(1):11-22. PubMed ID: 950773 [No Abstract] [Full Text] [Related]
45. Air-filled ultrasound contrast agents do not damage the cerebral microvasculature or brain tissue in rats. Haggag KJ; Russell D; Walday P; Skiphamn A; Torvik A Invest Radiol; 1998 Mar; 33(3):129-35. PubMed ID: 9525750 [TBL] [Abstract][Full Text] [Related]
46. Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique. Murakami H; Takanaga H; Matsuo H; Ohtani H; Sawada Y Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1022-8. PubMed ID: 10993764 [TBL] [Abstract][Full Text] [Related]
47. Morphology of the extravascular space in brain in comparison to other tissues. Wolff JR Bibl Anat; 1977; (15 Pt 1):210-2. PubMed ID: 597140 [No Abstract] [Full Text] [Related]
48. Certain aspects of drug distribution to brain. Oldendorf WH Adv Exp Med Biol; 1976; 69():103-9. PubMed ID: 941736 [No Abstract] [Full Text] [Related]
49. Some clinical aspects of the blood-brain barrier. Oldendorf WH Hosp Pract (Off Ed); 1982 Feb; 17(2):143-4, 151, 154 passim. PubMed ID: 6804352 [No Abstract] [Full Text] [Related]
50. Amphetamine-induced increase of the cerebrovascular permeability to protein. Johansson BB; Carlsson C Acta Neurol Scand Suppl; 1977; 64():62-3. PubMed ID: 268909 [No Abstract] [Full Text] [Related]
51. [Studies on the antigenicity problems of Hylase "Dessau"]. Müller HD Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1105-6. PubMed ID: 1226842 [No Abstract] [Full Text] [Related]
52. [Pharmacodynamic effect of the combined administration of Hylase "Dessau" and Myocuran in ambulatory surgery]. Bellmann H; Rauchfuss E; Böhland W; Scheuner G; Hutschenreiter J; Brand G; Sandner K Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1099-105. PubMed ID: 1226841 [No Abstract] [Full Text] [Related]
53. Permeability alteration of blood brain barrier by alcohols. Gulati A; Nath C; Dhawan KN; Shanker K; Bhargava KP Indian J Med Res; 1981 May; 73():793-5. PubMed ID: 7262954 [No Abstract] [Full Text] [Related]
54. An indicator-dilution technique for study of blood-to-brain solute passage in the rat. Murray JE; Plioplys A J Appl Physiol; 1972 Nov; 33(5):681-3. PubMed ID: 4564473 [No Abstract] [Full Text] [Related]